No Data
No Data
Viking Therapeutics Director Makes a Bold Stock Purchase!
Insider Purchase: Director at $VKTX Buys 1,240 Shares
Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?
Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month
Analysts Conflicted on These Healthcare Names: Zentalis Pharmaceuticals (ZNTL) and Viking Therapeutics (VKTX)
SA Asks: Which Cardiology Drug Companies Could Be Takeout Candidates?